Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.

Completed

Conditions: Breast Cancer

First Posted Date: 2020-07-08

Last Posted Date: 2024-01-11

Lead Sponsor: Pfizer

Target Recruit Count: 317

Registration Number: NCT04460911

Locations: 🇺🇸
Pfizer United States, New York, New York, United States

RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.

Completed

Conditions: Breast Cancer

First Posted Date: 2020-07-08

Last Posted Date: 2024-10-04

Lead Sponsor: Pfizer

Target Recruit Count: 195

Registration Number: NCT04460898

Locations: 🇺🇸
Pfizer United States, New York, New York, United States

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Phase 1

Terminated

Conditions: Neoplasm Metastasis

Interventions: Drug: PF-07265807
Drug: Sasanlimab
Drug: Axitinib

First Posted Date: 2020-07-07

Last Posted Date: 2025-06-06

Lead Sponsor: Pfizer

Target Recruit Count: 88

Registration Number: NCT04458259

Locations: 🇺🇸
Henry Eye Clinic, Fayetteville, Arkansas, United States
🇺🇸
Highlands Oncology Group, Springdale, Arkansas, United States
🇺🇸
UCI Chao Family Comprehensive Cancer Center, Orange, California, United States

and more 24 locations

InO - A Retrospective Study of UK Patients With Leukaemia

Completed

Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions: Drug: Inotuzumab Ozogamicin

First Posted Date: 2020-07-07

Last Posted Date: 2022-09-28

Lead Sponsor: Pfizer

Target Recruit Count: 28

Registration Number: NCT04456959

Locations: 🇬🇧
University College London Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧
University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
🇬🇧
The Royal Marsden NHS Foundation Trust of Fulham Road, London, United Kingdom

and more 1 locations

Investigation Of Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Doses Of Vupanorsen In Japanese Healthy Adult Participants With Elevated Triglycerides

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebo
Drug: Vupanorsen

First Posted Date: 2020-07-07

Last Posted Date: 2020-12-22

Lead Sponsor: Pfizer

Target Recruit Count: 12

Registration Number: NCT04459767

Locations: 🇯🇵
P-one Clinic, Hachioji-shi, Tokyo, Japan

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Phase 1

Completed

Conditions: Neurogenic Detrusor Overactivity

Interventions: Drug: Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B)
Drug: Fesoterodine BIC SR7 fasted (Treatment B in Part A, Treatment H in Part B)
Drug: Fesoterodine BIC SR7 fed (Treatment C in Part A, Treatment F in Part B)
Drug: Fesoterodine BIC SR4 fed (Treatment E in Part B)
Drug: Fesoterodine BIC SR7 on apple sauce (Treatment D in Part A)

First Posted Date: 2020-07-01

Last Posted Date: 2021-02-10

Lead Sponsor: Pfizer

Target Recruit Count: 37

Registration Number: NCT04452838

Locations: 🇧🇪
Brussels Clinical Research Unit, Brussels, Bruxelles-capitale, Région DE, Belgium

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Completed

Conditions: Major Depression

Interventions: Drug: Desvenlafaxine
Drug: Escitalopram
Drug: Paroxetine
Drug: Fluoxetine
Drug: Mirtazapine
Drug: Duloxetine
Drug: Sertraline
Drug: Venlafaxine
Drug: Tianeptine
Drug: Vortioxetine
Drug: Bupropion

First Posted Date: 2020-06-24

Last Posted Date: 2024-12-09

Lead Sponsor: Pfizer

Target Recruit Count: 370212

Registration Number: NCT04446039

Locations: 🇰🇷
Pfizer, Seoul, Korea, Republic of

MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age

Phase 3

Completed

Conditions: Meningococcal Vaccine

Interventions: Biological: MenABCWY
Biological: Trumenba
Biological: Saline
Biological: MenACWY-CRM

First Posted Date: 2020-06-19

Last Posted Date: 2023-04-18

Lead Sponsor: Pfizer

Target Recruit Count: 2431

Registration Number: NCT04440163

Locations: 🇺🇸
Fiel Family and Sports Medicine, PC/CCT Research, Tempe, Arizona, United States
🇺🇸
San Marcus Research Clinic, Inc., Miami Lakes, Florida, United States
🇺🇸
Holston Medical Group, Kingsport, Tennessee, United States

and more 70 locations

A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules

Phase 2

Completed

Conditions: Meningococcal Vaccine

Interventions: Biological: MenABCWY
Biological: Saline

First Posted Date: 2020-06-19

Last Posted Date: 2025-01-08

Lead Sponsor: Pfizer

Target Recruit Count: 309

Registration Number: NCT04440176

Locations: 🇺🇸
Alliance for Multispecialty Research, LLC, South Jordan, Utah, United States
🇺🇸
California Research Foundation, San Diego, California, United States
🇺🇸
Nona Pediatric Center, Orlando, Florida, United States

and more 13 locations

Treatment Resistance Following Anti-cancer Therapies

Not Applicable

Terminated

Conditions: Disease Progression

Interventions: Procedure: De novo tumor tissue biopsy
Procedure: Research blood draws

First Posted Date: 2020-06-17

Last Posted Date: 2024-12-03

Lead Sponsor: Pfizer

Target Recruit Count: 38

Registration Number: NCT04436120

Locations: 🇺🇸
Alaska Urological Institute dba Alaska Clinical Research Center, Anchorage, Alaska, United States
🇦🇷
Clínica Viedma S.A., Viedma, RIO Negro, Argentina
🇦🇷
Sanatorio de la Mujer, Rosario, Santa FÉ, Argentina

and more 26 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy